Health and pharmaceutical stocks — including Moderna (MRNA), Pfizer (PFE), BioNTech (BNTX), Novavax (NVAX ... opportunity to diversify their mRNA COVID-19 vaccine supply and gain access to pre-filled ...

The FDA will review a new prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted).

Practices related to predrawing the vaccine into unmarked plastic syringes were observed that could impact patient safety and reduce vaccine potency. If we consider the American birth cohort of 4 ...

She alleged her in-laws were not taking proper care of her children and showed the court her daughter's YouTube videos, one of which showed her posing with a syringe. Taking a stern view of the ...

Back in November 2023, pharmaphorum travelled to Uppsala, Sweden, for a Novavax press conference, the company celebrating a decade of doing what it does best: vaccines. From COVID-19 to malaria ...

Shares of this vaccine maker have returned -13.6% over the past month versus the Zacks S&P 500 composite's +1% change. The Zacks Medical - Biomedical and Genetics industry, to which Novavax ...

The first human bird flu death in the US has Moderna's vaccine development in focus for investors this week. Novavax (NVAX) witnessed a jump in share price last session on above-average trading ...

Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced progress in Q4 2024 advancing its corporate growth strategy through ...

Novavax has begun a late-stage trial of its experimental COVID-19 vaccine in the UK, which could support filings for a licence in the UK, EU and other countries.

Novavax (NVAX) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

Discover the advantages of needle-free vaccines and which companies are developing their own promising delivery solutions in ...